bosentan anhydrous has been researched along with malondialdehyde in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arya, DS; Gupta, SK; Saxena, A; Singh, U | 1 |
| Amit, S; Kumar, OS; Mukesh, N; Rajan, M; Singh, AD | 1 |
| Soydan, G; Tekes, E; Tuncer, M | 1 |
| Banoglu, ZN; Dengiz, GO; Kandemir, NO; Kurcer, Z; Mungan, G; Ozacmak, VH; Turkili, B | 1 |
| Akgun, B; Berilgen, SM; Demir, CF; Kaplan, M; Ozdemir, HH; Sarı, A | 1 |
| Ayaz, G; Baygutalp, NK; Bayir, Y; Calik, M; Demirci, E; Ferah, I; Gundogdu, C; Ozkanlar, S | 1 |
| Akpinar, E; Albayrak, A; Atmaca, HT; Bayraktutan, Z; Cayir, A; Cayir, Y; Kara, M; Kose, D; Ugan, RA | 1 |
7 other study(ies) available for bosentan anhydrous and malondialdehyde
| Article | Year |
|---|---|
Bosentan, the mixed ETA-ETB endothelin receptor antagonist, attenuated oxidative stress after experimental myocardial ischemia and reperfusion.
Topics: Animals; Bosentan; Cardiotonic Agents; Catalase; Endothelin Receptor Antagonists; Glutathione; Male; Malondialdehyde; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Oxidative Stress; Rats; Rats, Wistar; Sulfonamides; Superoxide Dismutase | 2005 |
Cardioprotective effects of bosentan, a mixed endothelin type A and B receptor antagonist, during myocardial ischaemia and reperfusion in rats.
Topics: Animals; Blood Pressure; Bosentan; Cardiotonic Agents; Creatine Kinase; Diastole; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Heart Rate; Male; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Wistar; Sulfonamides; Survival Analysis; Systole; Time Factors | 2006 |
Short-term and long-term FK506 treatment alters the vascular reactivity of renal and mesenteric vascular beds.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Bosentan; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Endothelin-1; Hypertension; Immunosuppressive Agents; Kidney; Male; Malondialdehyde; Mesentery; Nitroprusside; Norepinephrine; Oxidative Stress; Rats; Rats, Wistar; Receptor, Endothelin A; Sulfonamides; Tacrolimus; Time Factors; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2006 |
Role of angiotensin and endothelin in testicular ischemia reperfusion injury.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Bosentan; Enalapril; Endothelin Receptor Antagonists; Endothelins; Losartan; Male; Malondialdehyde; Rats; Rats, Wistar; Reperfusion Injury; Statistics, Nonparametric; Sulfonamides; Testis | 2012 |
Electrophysiological effects of bosentan in rats with induced cerebral ischemia-reperfusion.
Topics: Animals; Antihypertensive Agents; Bosentan; Brain Ischemia; Electroencephalography; Electrophysiological Phenomena; Female; Ischemia; Malondialdehyde; Neurons; Perfusion; Rats; Rats, Wistar; Reperfusion Injury; Sulfonamides | 2013 |
Endothelin receptor inhibition with bosentan delays onset of liver injury in streptozotocin-induced diabetic condition.
Topics: Animals; Bosentan; Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Experimental; Endothelin Receptor Antagonists; Endothelin-1; Gene Expression Regulation; Glutathione; Liver; Male; Malondialdehyde; Rats; Streptozocin; Sulfonamides; Superoxide Dismutase; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2015 |
The lung endothelin system: a potent therapeutic target with bosentan for the amelioration of lung alterations in a rat model of diabetes mellitus.
Topics: Acute Lung Injury; Animals; Bosentan; Diabetes Mellitus, Experimental; Endothelin Receptor Antagonists; Glutathione; Lung; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Sulfonamides; Superoxide Dismutase; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2015 |